Developing a successful market access strategy requires navigating complex global payer and health technology assessment (HTA) requirements, often across product classes and therapeutic areas. Our Value & Access experts work to provide actionable strategies to drive and demonstrate payer value throughout the development lifecycle to maximize a product’s success in today’s competitive market. Our experienced team leverages deep relationships with HTA bodies and payers in established and emerging markets to understand what shapes decision making and applies these insights to overcome payer challenges and ensure optimal pricing and access.